|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/337 | |
| A61K 31/7068 | |||
| A61K 31/35 | |||
| A61K 31/357 | |||
| A61K 31/282 | |||
| A61K 31/427 | |||
| A61K 31/555 | |||
| A61K 31/704 | |||
| A61K 33/24 | |||
| A61K 45/06 | |||
| A61P 35/00 | |||
| A61P 15/08 | |||
| C12Q 1/68 | |||
| A61K 9/00 |
| (11) | Patento numeris | 3148526 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15799560.6 |
| Europos patento paraiškos padavimo data | 2015-05-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-04-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-01-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/032684 |
| Data | 2015-05-27 |
| (87) | Numeris | WO 2015/183961 |
| Data | 2015-12-03 |
| (30) | Numeris | Data | Šalis |
| 201462003937 P | 2014-05-28 | US |
| (72) |
LITTLEFIELD, Bruce A., US
ASANO, Makoto, JP
MATSUI, Junji, JP
OLIVO, Martin, US
OZAWA, Yoichi, JP
YU, Yanke, US
|
| (73) |
Eisai R&D Management Co., Ltd.,
6-10 Koishikawa 4-chome, Tokyo 112-8088,
JP
|
| (54) | USE OF ERIBULIN IN THE TREATMENT OF CANCER |
| USE OF ERIBULIN IN THE TREATMENT OF CANCER |